Valerie Diane Valeriano and Bettina Ryll
Dec 9, 2024, 14:45
Bettina Ryll: Valerie Diane Valeriano at MPNE Hubs 2024 on how the microbiome modulates response to immune therapies in Melanoma
Bettina Ryll, Founder of MPN Europe, shared on LinkedIn:
“Listening to Valerie Diane Valeriano at MPNEhubs 2024 on how the microbiome modulates response to immune therapies in Melanoma and her work in the OncoBiome project.
A lot of considerations to turn an observation into something that could become a treatment a scale- and why designer microbiome consortia might be a good concept.
If you want to meet someone passionate about microbiota- you have to meet Valerie Diane Valeriano.”
Article 1: Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
More posts featuring Bettina Ryll.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 6, 2025, 11:54
Jan 6, 2025, 11:39
Jan 6, 2025, 11:11
Jan 6, 2025, 11:03
Jan 6, 2025, 10:45
Jan 6, 2025, 10:39